Maryana Liedke, DOMultiple Sclerosis Specialist
Dr. Maryana Liedke is board-certified in Neurology and fellowship-trained in Multiple Sclerosis. Dr. Liedke’s area of interest and expertise is to help people with MS, by providing patients with the latest treatment options backed by research and emerging science. She received her Doctor of Osteopathic Medicine degree from the Lake Erie College of Osteopathic Medicine in 2013 and completed an internship in Internal Medicine at Stony Brook University Hospital in 2014. She then completed her Neurology residency at Stony Brook University Hospital in 2017. She subsequently pursued additional fellowship training in Multiple Sclerosis at the Weill Cornell MS Center.
- 9/2017 - 5/2018 Weill Cornell Medicine Multiple Sclerosis Center New York Presbyterian Hospital, New York, New York Fellowship in New York Multiple Sclerosis
- 7/2014 - 6/2017 State University of New York at Stony Brook University Hospital Stony Brook,
New York Residency in General Neurology
- 7/2013 - 6/2014 State University of New York at Stony Brook University Hospital
Stony Brook, New York Preliminary IM Internship
- 7/2009 - 6/2013 Lake Erie College of Osteopathic Medicine Erie,
Pennsylvania Doctor of Osteopathic Medicine
- 8/2003 - 5/2007 Barnard College, Columbia University New York,
New York Bachelor of Arts, English
- 1/2019 - Present Mid Suffolk Neurology Ronkonkoma, NY Attending General Neurologist
- 1/2019 - Present State University of New York at Stony Brook University Hospital Renaissance School of Medicine Clinical Assistant Professor
- 4/2017 - 4/2022 Active, Unrestricted State Medical License State of New York License #288433
- 1/2020 - 3/2023 DEA License Reg. #FL6865084
- 2017 - 2027 Neurology American Board of Psychiatry and Neurology (ABPN) ID #60884
- Botox injections, trigger point injections, occipital nerve block injections, lumbar puncture
- Clinical Assistance Instructor for Stony Brook University Hospital School of Medicine teaching medical students at an out-patient general neurology office.
- American Academy of Neurology, American Medical Association, American Osteopathic Association
- Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS. Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS. J Neurol. 2018 May;265(5):1226-1229. doi: 10.1007/s00415-018-8845-4. Epub 2018 Apr 17. PMID:29666985.
Stony Brook University Hospital, Stony Brook, NY
- Research Investigating the importance of lumbar puncture in establishing the diagnosis of multiple sclerosis through retrospective chart review.